Location: Home
  • search
  • go
  • Relate News
  • 12/25/2017Shanghai Fines Chiesi Subsidiary for Organizing Tours for Physicians d...
  • 12/25/2017CFDA Solicits Comments on Draft Technical Requirements for Evaluation ...
  • 12/25/2017Draft Basic Healthcare and Health Promotion Law Submitted for Initial ...
  • 12/22/2017CFDA, NHFPC Solicit Comments on Measures for Filing Registration of Me...
  • 12/22/2017CFDA Issues Technical Guidelines for Research and Evaluation of Cellul...
  • 12/22/2017Zhejiang Medicine Terminates Development of Anticancer Puquitinib
  • 12/21/2017Protein Newly Created in China Key to Development of Vaccine Against C...
  • 12/21/2017GMP Certificate Cancellation in China: Concern Or Relief?
  • 12/21/2017TRACON and Ambrx Announce License Agreement for Carotuximab in China
  • 12/21/2017CANbridge LS Submits IND for CAN017 Trial in Esophageal Squamous Cell ...
  • 12/21/2017Recent Executive Moves
  • 12/21/2017vTv Therapeutics Licenses GLP-1r Agonist Diabetes Program to Huadong P...
  • 12/21/2017Janssen Enters License Agreement with Legend Biotech to Develop CAR-T ...
  • 12/21/2017Onconova, HanX Biopharma Enter License Agreement for Anticancer ON1233...
  • 12/21/2017Fast Rising Price of Chinese APIs Puts Pressure on Bottom Lines of Ind...
  • 12/20/2017Upcoming Event: Alzheimer 2018
  • 12/20/2017Review of Chinese Pharmaceutical Distribution Sector Performance H1/20...
  • 12/20/2017Review of Chinese Drug Clinical Trials on the Official Registration Pl...
  • 12/20/2017JSR Acquires CRO Crown Bioscience for NT$12B
  • 12/20/2017Jacobson Pharma and Shanghai Henlius Biotech Tie Up to Tap Biosimilars...
  • 12/20/2017CDE Solicits Comments on Technical Guidance for Conditional Approval o...
  • 12/20/2017CFDA Seeks Comments on Regulation for Expanded Compassionate Use of Cl...
  • 12/20/2017Five Prime Therapeutics and Zai Lab Announce License Deal for Anti-FGF...
  • 12/20/2017Examination Practice of Antibody-Related Patent Applications In China
  • 12/19/2017Patent Issues for Life Science Companies in China
  • 12/19/2017Legal Debriefs: The Revised Administrative Measures for Drug Registrat...
  • 12/19/2017Highlights On China's Comprehensive Regulatory Reform of Drugs and Med...
  • 12/19/2017WHO to Train More Autism Counselors In China
  • 12/19/2017BeiGene Initiates Pivotal Trial of PARP Inhibitor Pamiparib for Ovaria...
  • 12/19/2017Clover Biopharmaceuticals Completes CNY 62.8M Series A Financing
  • Page:285/720 Total number of articles:21580: [First][<<] [283] [284] [285] [286] [287] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group